doi:10.1016/j.cca.2008.12.027
Do not drink alcohol
A pooled analysis of the STEP 1-3 trials (n=2,117 semaglutide 2.4 mg, n=1,262 placebo) reported GI adverse events in 72.9% of the semaglutide group versus 47.1% of placebo, with nausea (43.9% vs 16.1%), diarrhea (29.7% vs 15.9%), vomiting (24.5% vs 6.3%), and constipation (24.2% vs 11.1%) the most common categories
SIH refers to elevated blood glucose levels during GCs therapy and includes both patients without and with pre-existing type 2 diabetes mellitus (T2DM)
This way, youll have everything you need for administering your dose at the right time
Yes, every medication has potential side effects and health risks, and these drugs are no different in that regard